COMPOUNDS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FAT LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

摘要

and their pharmaceutical and food grade acceptable salts, for use in the prevention and/or treatment of NAFLD (non-alcoholic fat liver disease) or NASH (non-alcoholic steatohepatitis), and related symptoms and/or associated pathologies thereof are described. Also described are pharmaceutical compositions or nutraceutical compositions comprising said compounds of formula I, and their pharmaceutically, or food grade, acceptable or allowable, salts and combinations thereof, optionally with any inert ingredient, carrier, excipient or alike for use in the prevention and/or treatment of NAFLD or NASH, and related symptoms and/or associated pathologies thereof. Additionally described are methods for the prevention and/or treatment of NAFLD or NASH, and related symptoms and/or associated pathologies thereof comprising the administration to a subject in need thereof, of any compound of formula I, and pharmaceutical and food grade acceptable salts thereof, or any pharmaceutical compositions, functional food additives or nutraceutical compositions comprising the same.